id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-347189-i9rzo3j0	Lorusso, Domenica	Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?	2020-10-13		.txt	text/plain	3312	162	42	The COVID-19 pandemic suggests that it is possible to alleviate redundancy in clinical trials, and while preserving the rigour of a study, can offer a new, less burdened and more inclusive vision of clinical research for the scientific community of tomorrow. Data from China reported that patients with cancer who are infected with COVID-19 are at 3.5 times the risk of requiring mechanical ventilation or intensive care unit (ICU) admission, compared with the general population. 4 Although conversion to telemedicine has maintained the continuity of care for many patients, the COVID-19 pandemic has massively disrupted clinical research and many cancer centres halted clinical trial activities including patient recruitment. COVID-19 has pointed out that sometimes, high level of bureaucracy in research rules place unnecessary burdens on patients and clinicians and it suggests that it is time to alleviate bureaucracy and introduce some practical changes into research organisation that will possibly promote patient access to trials and reduce the costs of the clinical research.	./cache/cord-347189-i9rzo3j0.txt	./txt/cord-347189-i9rzo3j0.txt